Michael A. Gerber

32.2k total citations · 8 hit papers
258 papers, 20.5k citations indexed

About

Michael A. Gerber is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Michael A. Gerber has authored 258 papers receiving a total of 20.5k indexed citations (citations by other indexed papers that have themselves been cited), including 139 papers in Epidemiology, 83 papers in Public Health, Environmental and Occupational Health and 71 papers in Infectious Diseases. Recurrent topics in Michael A. Gerber's work include Streptococcal Infections and Treatments (70 papers), Hepatitis B Virus Studies (52 papers) and Infective Endocarditis Diagnosis and Management (45 papers). Michael A. Gerber is often cited by papers focused on Streptococcal Infections and Treatments (70 papers), Hepatitis B Virus Studies (52 papers) and Infective Endocarditis Diagnosis and Management (45 papers). Michael A. Gerber collaborates with scholars based in United States, Germany and France. Michael A. Gerber's co-authors include Stanford T. Shulman, Jay H. Hoofnagle, Michael P. Manns, Peter J. Scheuer, Valeer Desmet, Kathryn A. Taubert, Patricia Ferrieri, Edward L. Kaplan, Swan N. Thung and Michael H. Gewitz and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Michael A. Gerber

254 papers receiving 19.3k citations

Hit Papers

Classification of chronic hepatitis: Diagnosis, grading a... 1992 2026 2003 2014 1994 1992 2004 2005 2004 500 1000 1.5k 2.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael A. Gerber United States 67 10.0k 5.7k 5.4k 4.7k 4.5k 258 20.5k
Henry Masur United States 88 17.4k 1.8× 10.4k 1.8× 2.9k 0.5× 2.0k 0.4× 3.4k 0.8× 375 33.5k
Kathryn M. Edwards United States 91 21.2k 2.1× 10.5k 1.8× 2.2k 0.4× 862 0.2× 2.2k 0.5× 557 31.2k
Per Ljungman Sweden 84 13.5k 1.4× 5.2k 0.9× 3.0k 0.6× 744 0.2× 1.7k 0.4× 489 29.3k
Shan‐Chwen Chang Taiwan 64 6.6k 0.7× 7.9k 1.4× 1.8k 0.3× 1.0k 0.2× 1.6k 0.3× 652 19.0k
Ron Dagan Israel 77 15.6k 1.6× 3.3k 0.6× 3.5k 0.7× 591 0.1× 1.4k 0.3× 597 22.2k
David R. Snydman United States 68 9.2k 0.9× 6.9k 1.2× 1.7k 0.3× 1.1k 0.2× 1.5k 0.3× 350 17.6k
Robert C. Holman United States 63 4.0k 0.4× 4.6k 0.8× 1.3k 0.2× 739 0.2× 2.2k 0.5× 218 11.9k
Jens Lundgren Denmark 91 12.0k 1.2× 19.9k 3.5× 925 0.2× 2.6k 0.5× 2.3k 0.5× 678 33.1k
Nicola Principi Italy 63 8.8k 0.9× 3.9k 0.7× 1.4k 0.3× 999 0.2× 1.3k 0.3× 591 16.5k
Gilbert Habib France 61 9.6k 1.0× 4.1k 0.7× 3.6k 0.7× 293 0.1× 4.9k 1.1× 358 18.7k

Countries citing papers authored by Michael A. Gerber

Since Specialization
Citations

This map shows the geographic impact of Michael A. Gerber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Gerber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Gerber more than expected).

Fields of papers citing papers by Michael A. Gerber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Gerber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Gerber. The network helps show where Michael A. Gerber may publish in the future.

Co-authorship network of co-authors of Michael A. Gerber

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Gerber. A scholar is included among the top collaborators of Michael A. Gerber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Gerber. Michael A. Gerber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gerber, Michael A.. (2009). Guidance helps pediatricians distinguish between viral, GAS pharyngitis and prevent rheumatic fever. AAP News. 30(6). 32–32. 2 indexed citations
2.
Bosshard, Georg, et al.. (2008). Rechtliche Grundlagen im medizinischen Alltag : ein Leitfaden für die Praxis. IRIS. 2 indexed citations
3.
Wendelboe, Aaron M., Elisabeth Njamkepo, A. Bourillon, et al.. (2007). Transmission of Bordetella pertussis to Young Infants. The Pediatric Infectious Disease Journal. 26(4). 293–299. 372 indexed citations
4.
Linam, W. Matthew & Michael A. Gerber. (2007). Changing Epidemiology and Prevention of Salmonella Infections. The Pediatric Infectious Disease Journal. 26(8). 747–748. 43 indexed citations
5.
Park, Sarah Y., Michael A. Gerber, Robert R. Tanz, et al.. (2006). Conducta clínica ante los niños y adolescentes con faringitis aguda. PEDIATRICS. 61(6). 382–388.
6.
Baddour, Larry M., Walter R. Wilson, Arnold S. Bayer, et al.. (2005). Infective Endocarditis. Circulation. 111(23). e394–434. 1204 indexed citations breakdown →
7.
Shapiro, Eugene D. & Michael A. Gerber. (2001). Late lyme disease: Clearing up confusion. Contemporary pediatrics. 1 indexed citations
8.
Simonsen, Lone, et al.. (2001). Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception. The Lancet. 358(9289). 1224–1229. 86 indexed citations
9.
Bisno, Alan L., Michael A. Gerber, Jack M. Gwaltney, Edward L. Kaplan, & Richard H. Schwartz. (1999). Diagnosis and Management of Group A Streptococcal Pharyngitis: A Practice Guideline. The American Journal of Managed Care. 5. 3 indexed citations
10.
Ratain, Mark J., Susan O’Brien, Nicola J. Cooper, et al.. (1997). Phase I study of 3′-deamino-3′-(2-methoxy-4-morpholinyl)doxorubicin (FCE 23762, PNU 152243) administered on a daily ×3 schedule. Annals of Oncology. 8(8). 807–809. 1 indexed citations
11.
Halsey, N. A., P. Joan Chesney, Michael A. Gerber, et al.. (1996). Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. PEDIATRICS. 97(1). 137–140. 113 indexed citations
12.
Thung, Swan N. & Michael A. Gerber. (1995). Differential diagnosis in pathology : liver disorders. 5 indexed citations
13.
Salazar, Juan C., et al.. (1993). Long-term outcome of Lyme disease in children given early treatment. The Journal of Pediatrics. 122(4). 591–593. 39 indexed citations
14.
Balart, Luis A., Robert Perrillo, Fredric Regenstein, et al.. (1993). Hepatitis C RNA in liver of chronic hepatitis C patients before and after interferon alfa treatment. Gastroenterology. 104(5). 1472–1477. 56 indexed citations
15.
Dajani, Adnan S., Elía M. Ayoub, Fredrick Z. Bierman, et al.. (1993). Guidelines for the diagnosis of rheumatic fever: Jones criteria, updated 1992: Special writing group of the committee on rheumatic fever, endocarditis, and Kawasaki disease of the council on cardiovascular disease in the young, American Heart Association. Circulation. 87(1). 302–307. 285 indexed citations
16.
Gerber, Michael A.. (1991). OFFICE CULTURES FOR GROUP A STREPTOCOCCI. PubMed. 10(12). 960–961. 1 indexed citations
17.
Gerber, Michael A. & Swan N. Thung. (1988). Hans Popper, MD, PhD: November 24, 1903—May 6, 1988. American Journal Of Pathology. 133(1). 13–14. 1 indexed citations
18.
Hyams, Jeffrey S., et al.. (1985). Colonic Ulceration in Histiocytosis X. Journal of Pediatric Gastroenterology and Nutrition. 4(2). 286–290. 1 indexed citations
19.
Chen, Meiling, et al.. (1984). Morphometric study of hepatocytes containing hepatitis B surface antigen.. PubMed Central. 114(2). 217–21. 12 indexed citations
20.
Thung, Swan N., Michael A. Gerber, Robert H. Purcell, et al.. (1981). Animal model of human disease. Chimpanzee carriers of hepatitis B virus. Chimpanzee hepatitis B carriers.. PubMed. 105(3). 114–115. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026